Am J Epidemiol 2003; 157:249-257.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
PRACTICE OF EPIDEMIOLOGY |
Multiple Informants: A New Method to Assess Breast Cancer Patients Comorbidity
1 Department of Epidemiology, Boston University School of Public Health, Boston, MA.
2 Geriatrics Section, Department of Medicine, Boston University School of Medicine, Boston, MA.
3 Department of Biostatistics, Boston University School of Public Health, Boston, MA.
4 General Internal Medicine Section, Department of Medicine, Boston University School of Medicine, Boston, MA.
5 Department of Health Care Policy, Harvard Medical School, Boston, MA.
Past assessments of comorbidity indices have sought to recommend a single index that performs better than others. The authors used a multiple informants approach as an alternative method to simultaneously assess five indices of comorbidity. This approach provides a single estimate of the overall effect of comorbidity and evaluates the relation any individual index has to the outcomes of interest. Association of comorbidity with definitive primary therapy, discussion of tamoxifen, and receipt of tamoxifen was evaluated in a cohort of 830 older breast cancer patients enrolled at four geographically distinct centers in the United States from 1996 to 1999. The estimated adjusted effect of a unit increase in comorbidity on the odds of discussing tamoxifen therapy was 0.70 (95% confidence interval: 0.56, 0.88). An increase in comorbidity was not associated with receipt of definitive primary therapy (odds ratio = 0.94, 95% confidence interval: 0.79, 1.13) or receipt of tamoxifen (odds ratio = 0.96, 95% confidence interval: 0.72, 1.27). The multiple informants regression proved superior to separate regression models that included only one index. In analyses that require comorbidity adjustment and for which no single index is expected to be ideal, the multiple informants approach is an attractive alternative to selecting a single index and to other methods of using multiple indices.
breast neoplasms; comorbidity; epidemiologic factors; epidemiologic methods
Abbreviations: Abbreviations: ASA, American Society of Anesthesiologists; ICED, Index of Coexistent Diseases.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-L. T. Normand Some Old and Some New Statistical Tools for Outcomes Research Circulation, August 19, 2008; 118(8): 872 - 884. [Full Text] [PDF] |
||||
![]() |
T. L. Lash, V. Mor, D. Wieland, L. Ferrucci, W. Satariano, and R. A. Silliman Methodology, Design, and Analytic Techniques to Address Measurement of Comorbid Disease J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 281 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L G Janssen-Heijnen, S Smulders, V E P P Lemmens, F W J M Smeenk, H J A A van Geffen, and J W W Coebergh Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer Thorax, July 1, 2004; 59(7): 602 - 607. [Abstract] [Full Text] [PDF] |
||||


